首页|复合型髋臼骨折围手术期多次静脉使用氨甲环酸的有效性及安全性评价

复合型髋臼骨折围手术期多次静脉使用氨甲环酸的有效性及安全性评价

扫码查看
目的 探讨复合型髋臼骨折围手术期多次静脉使用氨甲环酸(tranexamic acid,TXA)减少失血的有效性和安全性。方法 选择2021年9月-2022年12月四川大学华西医院骨科/创伤医学中心收治的复合型髋臼骨折拟行手术患者。按照TXA的不同使用方案,采用随机数字表法随机将纳入患者分为对照组和试验组。观察纳入患者的一般资料、总失血量、术后48 h引流量、隐性失血量、纤溶指标、输血率及静脉血栓事件发生率。结果 共纳入患者60例,其中男41例,女19例;每组各30例。两组患者的性别、年龄、体质量指数、手术入路及手术时长比较,差异均无统计学意义(P>0。05)。对照组和试验组的总失血量[(795。90±451。36)vs。(579。70± 315。88)mL]、术后 48 h 引流量[(231。33±130。77)vs。(147。67±73。14)mL]、隐性失血量[(406。23±356。17)vs。(170。30±163。75)mL]、输血率(63。3%vs。36。7%)比较,差异均有统计学意义(P<0。05)。两组患者术前的肌间静脉血栓发生率,术后的深静脉血栓和肌间静脉血栓发生率比较,差异均无统计学意义(P>0。05)。所有患者术后均未发生肺栓塞。两组的血红蛋白、红细胞压积均随时间下降(P<0。05),但整体水平比较差异均无统计学意义(P>0。05)。两组的纤维蛋白原、D-二聚体呈现不同变化趋势(P<0。05),且试验组优于对照组。结论 对于复合型髋臼骨折围手术期多次静脉使用TXA能有效减少患者总失血量、隐性失血量,减少围手术期输血率,且不增加静脉血栓性疾病发生。
Evaluation of efficacy and safety of perioperative multiple intravenous tranexamic acid administration in complex acetabular fractures
Objective To explore the efficacy and safety of perioperative multiple intravenous tranexamic acid(TXA)administration in complex acetabular fracture.Methods The patients with complex acetabular fractures admitted to the Department of Orthopedic Surgery/Trauma Center of West China Hospital,Sichuan University between September 2021 and December 2022 for a planned surgery were selected.The patients were randomly divided into a control group and an experimental group according to TXA administration protocol.The general information,total blood loss,48 h postoperative blood drainage,recessive blood loss,fibrinolysis index,transfusion rate,and incidence of venous thrombotic events of the included patients were observed.Results A total of 60 patients were included,including 41 males and 19 females;30 cases in each group.There was no statistically significant difference in gender,age,body mass index,surgical approach,and surgical duration between the two groups of patients(P>0.05).There were statistically significant differences in total blood loss[(795.90±451.36)vs.(579.70±315.88)mL],48 h postoperative blood drainage[(231.33±130.77)vs.(147.67±73.14)mL],recessive blood loss[(406.23±356.17)vs.(170.30±163.75)mL],and transfusion rate(63.3%vs.36.7%)between the control group and the experimental group(P<0.05).There was no statistically significant difference in the preoperative incidence of intramuscular vein thrombosis and the postoperative incidence of deep vein thrombosis and intramuscular vein thrombosis between the two groups of patients(P>0.05).All patients did not experience pulmonary embolism after surgery.The hemoglobin and hematocrit of both groups showed a decreasing trend.But there was no statistically significant difference in hemoglobin and hematocrit between the two groups(P>0.05).Both groups showed different trends in fibrinogen and D-dimer,and the experimental group was better than the control group(P<0.05).Conclusion Multiple intravenous administration of TXA in complex acetabular fractures patients has proven to decrease the total and hidden blood loss,decrease perioperative blood products transfusion rate,and do not expose to venous thrombotic diseases risks.

Complex acetabular fractureperioperativemultiple intravenoustranexamic acidefficacy and safety

余游、邹昌、谭鹏、Guy Romeo Kenmegne、尹一杰、黄申博、何帅、方跃

展开 >

四川大学华西医院骨科/创伤医学中心(成都 610041)

复合型髋臼骨折 围手术期 多次静脉 氨甲环酸 有效性及安全性

2024

华西医学
四川大学华西医院

华西医学

CSTPCD
影响因子:0.744
ISSN:1002-0179
年,卷(期):2024.39(3)
  • 35